Income Statement (TTM)
Ananda Pharma Plc Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2024 04-30 |
2024 07-31 |
2024 10-31 |
2025 01-31 |
|
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Change (%) | 100.00 | -45.94 | -84.99 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Gross Operating Profit | 0 | 0 | 0 | 0 |
| Change (%) | 100.00 | -45.94 | -84.99 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 2 | 2 | 2 | 3 |
| Change (%) | -2.53 | 36.95 | 26.98 | |
| % of Revenue | 453,570.16 | 221,057.46 | 560,043.58 | 4,737,227.42 |
| R&D | ||||
| Change (%) | ||||
| % of Revenue | ||||
| OpEx | 3 | 3 | 3 | 4 |
| Change (%) | 2.10 | 7.71 | 7.16 | |
| % of Revenue | 793,242.15 | 404,950.00 | 806,884.50 | 5,759,753.23 |
| Operating Income | -3 | -3 | -3 | -4 |
| Change (%) | 2.09 | 7.73 | 7.17 | |
| % of Revenue | -793,142.15 | -404,850.00 | -806,784.50 | -5,759,653.23 |
| Interest Expense | -0 | -0 | -0 | -0 |
| Change (%) | 26.43 | -3.95 | -4.11 | |
| % of Revenue | -49,388.74 | -31,220.29 | -55,474.58 | -354,350.00 |
| Net Income | -6 | -6 | -5 | -4 |
| Change (%) | 1.78 | -20.42 | -25.67 | |
| % of Revenue | -1,639,388.48 | -834,311.65 | -1,228,163.20 | -6,081,430.65 |
Source: Capital IQ
